基于网络药理学和试验验证分析小檗碱治疗鸡沙门菌感染的作用机制

doi:10.11843/j.issn.0366-6964.2023.08.039

畜牧兽医学报 ›› 2023, Vol. 54 ›› Issue (8): 3557-3570.doi: 10.11843/j.issn.0366-6964.2023.08.039

基于网络药理学和试验验证分析小檗碱治疗鸡沙门菌感染的作用机制

张旭梅^1,5, 魏玉荣^2,3, 许丞惠^1,5, 杨彤^1,5, 史慧君^1,5, 付强^1,5, 杨莉^1,4,5*

1. 新疆农业大学动物医学学院, 乌鲁木齐 830052;
2. 新疆动物疫病研究重点实验室, 乌鲁木齐 830013;
3. 新疆畜牧科学院兽医研究所, 乌鲁木齐 830013;
4. 新疆农业大学畜牧学博士后流动站, 乌鲁木齐 830052;
5. 新疆草食动物新药研究与创制重点实验室, 乌鲁木齐 830052

收稿日期:2022-10-31 出版日期:2023-08-23 发布日期:2023-08-22
通讯作者: 杨莉,主要从事兽医药理学研究,E-mail:563289492@qq.com
作者简介:张旭梅(1999-),女,四川乐山人,硕士生,主要从事兽医药理学研究,E-mail:1564546821@qq.com;魏玉荣(1987-),女,甘肃民勤人,研究员,博士,主要从事动物传染病研究,E-mail:weiyu1113@sina.com。
基金资助:
新疆维吾尔自治区自然基金（2022D01B21）；高校科研计划自然科学青年项目（XJEDU2021Y022）；国家自然科学基金（32260902）

To Analyze the Mechanism of Berberine in the Treatment of Salmonella Gallinarum Infection Based on Network Pharmacology and Experimental Verification

ZHANG Xumei^1,5, WEI Yurong^2,3, XU Chenghui^1,5, YANG Tong^1,5, SHI Huijun^1,5, FU Qiang^1,5, YANG Li^1,4,5*

1. College of Animal Medicine, Xinjiang Agricultural University, Urumqi 830052, China;
2. Xinjiang Key Laboratory of Animal Disease Research, Urumqi 830013, China;
3. Institute of Veterinary Medicine, Xinjiang Academy of Animal Science, Urumqi 830013, China;
4. Postdoctoral Station of Animal Husbandry, Xinjiang Agricultural University, Urumqi 830052, China;
5. Xinjiang Key Laboratory of Herbivore New Drug Research and Creation, Urumqi 830052, China

Received:2022-10-31 Online:2023-08-23 Published:2023-08-22

摘要/Abstract

摘要： 采用网络药理学、分子对接、分子动力学模拟等方法，结合沙门菌攻毒试验初步验证小檗碱（berberine，BBR）干预肉鸡肠炎的潜在靶点及作用机制。首先利用PharMapper数据库和Swisstargets数据库预测药物靶点；通过GeneCards数据库收集疾病靶点，并筛选出药物和疾病靶点的交集，将得到的交集靶点构建蛋白质互作网络及GO与KEGG富集分析；对筛选出的核心靶点进行分子对接验证和动力学模拟；后续建立肉鸡肠道炎症模型，观察其肠道组织形态变化，并利用RT-qPCR验证BBR对靶点蛋白mRNA表达量的影响。结果显示：最终筛选得到BBR潜在靶点374个，与肠炎交集174个；GO与KEGG富集分析分别得到197条目和73条目，主要涉及信号转导、蛋白磷酸化过程及PI3K-Akt、趋化因子及Ras等信号通路；分子对接和动力学模拟结果显示，BBR与核心靶点之间均能较好地结合，主要通过疏水作用力、氢键结合；组织切片结果发现，BBR可显著缓解肠道组织损伤；RT-qPCR结果显示，给药后仔鸡盲肠组织中HSP90AA1表达量显著下降（P<0.001），PIK3CA表达量显著上升（P<0.01）。通过网络药理学和试验验证发现，BBR可能通过调节HSP90AA1和PIK3CA表达量来调控肠道炎症的发生发展，可能涉及PI3K-Akt、cAMP、AMPK等信号通路，为深入进行BBR治疗肠炎的作用机制研究提供新思路与新方法。

关键词: 网络药理学, 小檗碱, 肠炎, 分子对接, 作用机制

Abstract: The objective of this study was to preliminaries verify the potential target and mechanism of berberine (BBR) in the intervention of enteritis in broilers by using network pharmacology, molecular docking and molecular dynamics simulation combined with Salmonella challenge test. Firstly, PharMapper database and Swisstargets database were used to predict drug targets. The disease targets were collected through the GeneCards database, and the intersection of drugs and disease targets was screened. The obtained intersection targets were used to construct protein interaction network and GO and KEGG enrichment analysis. Molecular docking verification and kinetic simulation were carried out for the selected core targets. Subsequently, the intestinal inflammation model of broilers was established to observe the morphology changes of intestinal tissue, and the effect of BBR on the mRNA expression of target protein was verified by qPCR test. Finally, 374 potential BBR targets were screened, and 174 overlapped with enteritis. GO and KEGG enrichment analysis obtained 197 items and 73 items, respectively, which mainly involved signal transduction, protein phosphorylation process, PI3K-Akt, chemokine and Ras signaling pathway. The results of molecular docking and kinetic simulation showed that BBR could bind well to the core target, mainly through hydrophobic force and hydrogen bond. The results of tissue section showed that BBR could significantly alleviate intestinal tissue injury. The results of RT-qPCR showed that the expression of HSP90AA1 was significantly decreased (P<0.001), and the expression of PIK3CA was significantly increased (P<0.01) in cecal tissue of the inflammatory model of broilers. Through network pharmacology and experimental verification, it was found that BBR may regulate the occurrence and development of intestinal inflammation by regulating the expression of HSP90AA1 and PIK3CA, which may involve PI3K-Akt, cAMP, AMPK and other signaling pathways, providing new ideas and methods for further research on the mechanism.

Key words: network pharmacology, berberine, enteritis, molecular docking, mechanism of action

中图分类号:

S853.74

张旭梅, 魏玉荣, 许丞惠, 杨彤, 史慧君, 付强, 杨莉. 基于网络药理学和试验验证分析小檗碱治疗鸡沙门菌感染的作用机制[J]. 畜牧兽医学报, 2023, 54(8): 3557-3570.

ZHANG Xumei, WEI Yurong, XU Chenghui, YANG Tong, SHI Huijun, FU Qiang, YANG Li. To Analyze the Mechanism of Berberine in the Treatment of Salmonella Gallinarum Infection Based on Network Pharmacology and Experimental Verification[J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(8): 3557-3570.

参考文献 37

[1]	张小龙. 空肠菌群通过调节炎症反应影响鸡生长性能的机理研究[D]. 武汉:华中农业大学, 2021.ZHANG X L. Study on mechanism of Jejunal microbiota affects chicken growth performance by regulating inflammatory response[D]. Wuhan:Huazhong Agricultural University, 2021. (in Chinese)
[2]	WOTZKA S Y, NGUYEN B D, HARDT W D. Salmonella typhimurium diarrhea reveals basic principles of enteropathogen infection and disease-promoted DNA exchange[J]. Cell Host Microbe, 2017, 21(4):443-454.
[3]	MA T, XU L, WANG H, et al. Identification of the crucial genes in the elimination and survival process of Salmonella enterica ser. Pullorum in the chicken spleen[J]. Anim Genet, 2017, 48(3):303-314.
[4]	FLOCKHART L, PINTAR K, COOK A, et al. Distribution of Salmonella in humans, production animal operations and a watershed in a FoodNet Canada sentinel site[J]. Zoonoses Public Health, 2017, 64(1):41-52.
[5]	COLLINS J P, SHAH H J, WELLER D L, et al. Preliminary incidence and trends of infections caused by pathogens transmitted commonly through food-foodborne diseases active surveillance network, 10 U. S. Sites, 2016-2021[J]. MMWR Morb Mortal Wkly Rep, 2022, 71(40):1260-1264.
[6]	KIM W H, LILLEHOJ H S. Immunity, immunomodulation, and antibiotic alternatives to maximize the genetic potential of poultry for growth and disease response[J]. Anim Feed Sci Technol, 2019, 250:41-50.
[7]	SWAGGERTY C L, CALLAWAY T R, KOGUT M H, et al. Modulation of the immune response to improve health and reduce foodborne pathogens in poultry[J]. Microorganisms, 2019, 7(3):65.
[8]	徐晓帆. 小檗碱对葡聚糖硫酸钠诱导的小鼠肠炎的治疗效果与机制[D]. 武汉:华中农业大学, 2021.XU X F. Therapeutic effect and mechanism of Berberine on dextran sodium sulfate-induced intestinal inflammation in mice[D]. Wuhan:Huazhong Agricultural University, 2021. (in Chinese)
[9]	YARLA N S, BISHAYEE A, SETHI G, et al. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy[J]. Semin Cancer Biol, 2016, 40-41:48-81.
[10]	HESARI A, GHASEMI F, CICERO A F G, et al. Berberine:a potential adjunct for the treatment of gastrointestinal cancers?[J]. J Cell Biochem, 2018, 119(12):9655-9663.
[11]	PIRILLO A, CATAPANO A L. Berberine, a plant alkaloid with lipid-and glucose-lowering properties:from in vitro evidence to clinical studies[J]. Atherosclerosis, 2015, 243(2):449-461.
[12]	LI B H, NIU S P, GENG H L, et al. Berberine attenuates neonatal sepsis in mice by inhibiting FOXA1 and NF-κB signal transduction via the induction of MiR-132-3p[J]. Inflammation, 2021, 44(6):2395-2406.
[13]	CAI Y, XIN Q Q, LU J J, et al. A new therapeutic candidate for cardiovascular diseases:berberine[J]. Front Pharmacol, 2021, 12:631100.
[14]	SONG D Y, HAO J Y, FAN D M. Biological properties and clinical applications of berberine[J]. Front Med, 2020, 14(5):564-582.
[15]	YANG L, LIU G, LIANG X R, et al. Effects of berberine on the growth performance, antioxidative capacity and immune response to lipopolysaccharide challenge in broilers[J]. Anim Sci J, 2019, 90(9):1229-1238.
[16]	JIANG Y, ZHAO L, CHEN Q, et al. Exploring the mechanism of Berberine intervention in ulcerative colitis from the perspective of inflammation and immunity based on systemic pharmacology[J]. Evid Based Complement Alternat Med, 2021, 2021:9970240.
[17]	郭乙冰, 汪水平, 刘国威, 等. 小檗碱对炎症性肠病的调控机制[J]. 动物营养学报, 2018, 30(11):4363-4368.GUO Y B, WANG S P, LIU G W, et al. Regulation mechanisms of berberine on inflammatory bowel disease[J]. Chinese Journal of Animal Nutrition, 2018, 30(11):4363-4368. (in Chinese)
[18]	LI H, FAN C, LU H M, et al. Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions[J]. Acta Pharm Sin B, 2020, 10(3):447-461.
[19]	张彦琼, 李梢. 网络药理学与中医药现代研究的若干进展[J]. 中国药理学与毒理学杂志, 2015, 29(6):883-892.ZHANG Y Q, LI S. Progress in network pharmacology for modern research of traditional Chinese medicine[J]. Chinese Journal of Pharmacology and Toxicology, 2015, 29(6):883-892. (in Chinese)
[20]	SONG K H, OH S J, KIM S, et al. HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors[J]. Nat Commun, 2020, 11(1):562.
[21]	HOTER A, NAIM H Y. The functions and therapeutic potential of heat shock proteins in inflammatory bowel disease-an update[J]. Int J Mol Sci, 2019, 20(21):5331.
[22]	YANG M, ZHANG F, YANG C H, et al. Oral targeted delivery by nanoparticles enhances efficacy of an Hsp90 inhibitor by reducing systemic exposure in murine models of colitis and colitis-associated cancer[J]. J Crohns Colitis, 2020, 14(1):130-141.
[23]	SU Y H, TANG W C, CHENG Y W, et al. Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer[J]. Biochim Biophys Acta Mol Cell Res, 2015, 1853(10):2261-2272.
[24]	WANG X, JI Y G, FENG P P, et al. The m6A reader IGF2BP2 regulates macrophage phenotypic activation and inflammatory diseases by stabilizing TSC1 and PPARγ[J]. Adv Sci, 2021, 8(13):2100209.
[25]	EUN C S, HAN D S, LEE S H, et al. Attenuation of colonic inflammation by PPARγ in intestinal epithelial cells:effect on Toll-like receptor pathway[J]. Dig Dis Sci, 2006, 51(4):693-697.
[26]	FENG A W, YU C, MAO Q, et al. Berberine hydrochloride attenuates cyclooxygenase-2 expression in rat small intestinal mucosa during acute endotoxemia[J]. Fitoterapia, 2011, 82(7):976-982.
[27]	FENG A W, GAO W, ZHOU G R, et al. Berberine ameliorates COX-2 expression in rat small intestinal mucosa partially through PPARγ pathway during acute endotoxemia[J]. Int Immunopharmacol, 2012, 12(1):182-188.
[28]	IORGA A, DARA L, KAPLOWITZ N. Drug-induced liver injury:cascade of events leading to cell death, apoptosis or necrosis[J]. Int J Mol Sci, 2017, 18(5):1018.
[29]	范碧玥, 王萌, 潘阳阳, 等. 连翘叶酶-醇提取物抗药物性肝损伤作用研究[J]. 西北农林科技大学学报(自然科学版), 2022, 50(10):23-33.FAN B Y, WANG M, PAN Y Y, et al. Protective mechanism of forsythia suspense leaves extract against drug-induced liver injury[J]. Journal of Northwest A & F University (Natural Science Edition), 2022, 50(10):23-33. (in Chinese)
[30]	HUANG X L, XU J, ZHANG X H, et al. PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis[J]. Inflamm Res, 2011, 60(8):727-734.
[31]	LI Q J, QU X Y, PANG X G, et al. Berberine protects mice against dextran sulfate sodium-induced colitis by activating mTORC1 pathway[J]. Front Pharmacol, 2019, 10:786.
[32]	王佳俊, 王建, 李勇, 等. 基于细胞信号通路探讨小檗碱治疗溃疡性结肠炎研究进展[J]. 中国中药杂志, 2021, 46(1):33-40.WANG J J, WANG J, LI Y, et al. Research progress of effect of berberine in treatment of ulcerative colitis based on cell signaling pathway[J]. China Journal of Chinese Materia Medica, 2021, 46(1):33-40. (in Chinese)
[33]	WU J S, ZHANG H, HU B Y, et al. Coptisine from Coptis chinensis inhibits production of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 murine macrophage cells[J]. Eur J Pharmacol, 2016, 780:106-114.
[34]	FAN X D, WANG J, HOU J C, et al. Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway[J]. J Transl Med, 2015, 13:92.
[35]	范红云, 段志英, 赵亚男, 等. 舍曲林对肠易激综合征大鼠cAMP/PKA通路及肠道炎症反应的影响[J]. 中国免疫学杂志, 2022, 38(5):525-530.FAN H Y, DUAN Z Y, ZHAO Y N, et al. Effects of sertraline on cAMP/PKA pathway and intestinal inflammatory response in rats with irritable bowel syndrome[J]. Chinese Journal of Immunology, 2022, 38(5):525-530. (in Chinese)
[36]	刘方舟, 李萌, 李园白, 等. 基于网络药理学和分子对接技术研究复方芩兰口服液治疗新型冠状病毒肺炎(COVID-19)的作用机制[J]. 世界科学技术-中医药现代化, 2022, 24(3):1006-1019.LIU F Z, LI M, LI Y B, et al. Study on mechanism of compound Qinlan oral liquid in treatment of COVID-19 by network pharmacology and molecular docking technology[J]. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology, 2022, 24(3):1006-1019. (in Chinese)
[37]	HASSANEIN E H M, KAMEL E O, ALI F E M, et al. Berberine and/or zinc protect against methotrexate-induced intestinal damage:Role of GSK-3β/NRF2 and JAK1/STAT-3 signaling pathways[J]. Life Sci, 2021, 281:119754.

基于网络药理学和试验验证分析小檗碱治疗鸡沙门菌感染的作用机制

To Analyze the Mechanism of Berberine in the Treatment of Salmonella Gallinarum Infection Based on Network Pharmacology and Experimental Verification

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 37

相关文章 15

编辑推荐

Metrics

本文评价

[1]	巩志国, 赵佳敏, 顾柏臣, 任佩佩, 于琢雅, 白云洁, 刘鑫煜, 王超, 刘博. 基于网络药理学分析党参减轻大肠杆菌感染小鼠急性肺损伤的作用机制[J]. 畜牧兽医学报, 2023, 54(8): 3571-3581.
[2]	周炜炜, 王雪峰, 张梦洁, 杨娟, 孙悦龙, 张祖烽, 张宇欣, 豆佳红, 王梓颖, 戴小枫, 李秀梅. 基于生物网络功能模块整合组方规律分析四黄止痢颗粒治疗仔猪腹泻的作用机制[J]. 畜牧兽医学报, 2023, 54(7): 3031-3043.
[3]	姜美涵, 魏金涛, 呙于明, 郭双双, 杜恩存. 植物精油对产气荚膜梭菌感染肉仔鸡肠道损伤、肠道菌群CAZy谱和eggNOG通路的影响[J]. 畜牧兽医学报, 2023, 54(6): 2448-2457.
[4]	杨子辉, 董朕, 伍蕙岚, 谭斌, 曾建国. 基于网络药理学分析蒲公英抗氧化功能的物质基础与作用机制[J]. 畜牧兽医学报, 2023, 54(5): 2170-2185.
[5]	吕荞, 赵钟毅, 尹德玮, 刘宇梦, 汪伟, 郑敏, 胡诗悦, 赵宸辰, 张昕宇, 雷晓哓, 陆景仪, 孙文超, 兰添. 猪传染性胃肠炎病毒荧光RT-RAA方法的建立及初步应用[J]. 畜牧兽医学报, 2023, 54(5): 2208-2214.
[6]	潘婵媛, 赵梓轩, 段铭洁, 蒋林树, 童津津. 基于网络药理学预测青蒿缓解奶牛氧化应激的作用机制[J]. 畜牧兽医学报, 2023, 54(3): 1071-1084.
[7]	汪倩, 王建梅, 安柯颖, 夏兆飞. 增益素对溃疡性结肠炎犬免疫功能、肠道屏障和肠道菌群的影响[J]. 畜牧兽医学报, 2023, 54(3): 1261-1272.
[8]	单强, 王雪, 朱要宏, 王九峰. 鼠李糖乳杆菌抗炎机制及其在防治家畜疾病中的应用前景[J]. 畜牧兽医学报, 2023, 54(11): 4537-4550.
[9]	贺叶青, 左百姣, 李庆豪, 孙娟, 金鑫, 夏璐, 魏战勇. 猪传染性胃肠炎病毒感染仔猪免疫器官的组织病理学观察[J]. 畜牧兽医学报, 2023, 54(11): 4872-4879.
[10]	杨志梅, 梁成成, 张殿琦, 李雪峰, 昝林森. m⁶A修饰调控circRNA的研究进展[J]. 畜牧兽医学报, 2023, 54(10): 4016-4027.
[11]	崔恩慧, 薛玉环, 李辞霞, 王帅, 朱晓岩, 柴学军, 赵善廷. 杜仲叶免疫调节机制的网络药理学分析及验证[J]. 畜牧兽医学报, 2023, 54(1): 403-413.
[12]	孙栋, 屈莎, 李璇, 唐善虎, 李思宁, 郝刚. 抗菌肽Tachyplesin Ⅰ及衍生物对大肠杆菌细胞膜作用机制的对比研究[J]. 畜牧兽医学报, 2022, 53(9): 3180-3189.
[13]	杨伏春, 刘芮, 李晓涵, 高立, 刘长军, 祁小乐, 崔红玉, 王笑梅, 高玉龙, 李凯. 鸭肠炎病毒UL41基因缺失株的构建及其体外增殖能力分析[J]. 畜牧兽医学报, 2022, 53(8): 2689-2696.
[14]	田薇, 李秀梅, 杨娟, 王小莹, 周炜炜, 李中媛, 戴小枫. 基于网络药理学研究板蓝根抑菌活性成分及其作用机制[J]. 畜牧兽医学报, 2022, 53(8): 2782-2793.
[15]	刘魏魏, 张宇欣, 李秀梅, 王秀敏, 周炜炜, 戴小枫. 基于网络药理学分析桑叶增强鸡抗氧化功能的作用机制[J]. 畜牧兽医学报, 2022, 53(6): 1958-1970.